High mobility group box 1 antibody represses autophagy and alleviates hippocampus damage in pilocarpine-induced mouse epilepsy model.
Autor: | Ying C; Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, People's Republic of China; Department of Geratology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, People's Republic of China., Ying L; Department of General Medicine, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, People's Republic of China., Yanxia L; Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, People's Republic of China., Le W; Department of Neurology, Dezhou People's Hospital, Dezhou, Shandong 253014, People's Republic of China., Lili C; Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, People's Republic of China. Electronic address: qlyycll@163.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Acta histochemica [Acta Histochem] 2020 Feb; Vol. 122 (2), pp. 151485. Date of Electronic Publication: 2019 Dec 20. |
DOI: | 10.1016/j.acthis.2019.151485 |
Abstrakt: | As a neurological disorder, epilepsy has affected over 65 million people all over the world because of the unforeseeable seizures it might cause. However, in-depth understandings of the pathogenesis of epilepsy and effective treatments for the disease are still lacked. Recent discoveries suggest that autophagy, as an endogenous self-cleansing pathway in mammals, might be involved in the onset of epilepsy. Our study assumes that a non-histone DNA binding protein, high mobility group box-1 (HMGB1), formerly considered as a crucial inflammatory factor, may mediate the autophagy of neurons in epileptic mouse brain. To verify this hypothesis, pilocarpine induced epilepsy mouse model was constructed. The mice were treated with HMGB1 antibody for 4 weeks after the initial epileptic seizure. Behavioral test results suggested a recovery of learning ability and memory in epileptic mice when treated with HMGB1 antibody. Pathological changes in hippocampus were inspected under microscopes and hippocampus damages caused by seizures in mouse with epilepsy such as increased intracellular space were alleviated by HMGB1 antibody treatment. Moreover, the expressions of the proteins involved in autophagy pathways were detected by immunofluorescence staining and western blot. microtubule-associated protein 1A/1B-light chain 3 (LC3), Beclin 1, autophagy protein-5 (ATG5), and ATG7 levels were significantly decreased by HMGB1 antibody while the level of p62 was increased. TdT-mediated dUTP Nick-End Labeling (TUNEL) illustrated that cell apoptosis induced by seizures in hippocampus was mitigated by HMGB1 antibody. In conclusion, we propose that HMGB1 may induce increased autophagy in epilepsy mouse model. Competing Interests: Declaration of Competing Interest We would like to declare on behalf of our co-authors that the work entitled “High mobility group box 1 antibody represses autophagy and alleviates hippocampus damage in pilocarpine-induced mouse epilepsy model” has not been published previously, and not under consideration for publication elsewhere, in whole or in part. There is no interest conflict in this study. (Copyright © 2019 Elsevier GmbH. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |